Literature DB >> 8100163

Deletions in the prion protein gene are not associated with CJD.

M S Palmer1, S P Mahal, T A Campbell, A F Hill, K C Sidle, J L Laplanche, J Collinge.   

Abstract

The human prion diseases (spongiform encephalopathies) Creutzfeldt-Jakob disease (CJD) and Gerstmann-Sträussler syndrome (GSS), are neurodegenerative disorders characterised by the accumulation of an abnormal isoform of the prion protein. The normal prion protein is a phosphatidyl inositol anchored, membrane bound sialoglycoprotein of widespread tissue distribution but expressed predominantly in the brain. 15% of prion diseases are autosomal dominant genetic disorders associated with mutations in the gene encoding the prion protein. To date six pathogenic amino acid substitutions have been identified in affected family members, in addition to five distinct insertional events which occur within a region of the protein comprising four tandem octapeptide repeats. We have investigated deletions within this region and have identified three specific deletions. We report here that these deletions are not associated with CJD and represent a new class of polymorphism within the prion protein gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100163     DOI: 10.1093/hmg/2.5.541

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  19 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.

Authors:  U Finckh; T Müller-Thomsen; U Mann; C Eggers; J Marksteiner; W Meins; G Binetti; A Alberici; C Hock; R M Nitsch; A Gal
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  Prnp gene and cerebellum volume in patients with refractory mesial temporal lobe epilepsy.

Authors:  Michelle N Valadão; Erica R Coimbra; Michele C Landemberger; Tonicarlo R Velasco; Vera C Terra; Lauro Wichert-Ana; Veriano Alexandre; David Araújo; Ricardo Guarnieri; Vilma R Martins; Antônio Carlos Santos; Américo C Sakamoto; Roger Walz
Journal:  Neurol Sci       Date:  2013-10-05       Impact factor: 3.307

Review 4.  Hereditary Human Prion Diseases: an Update.

Authors:  Matthias Schmitz; Kathrin Dittmar; Franc Llorens; Ellen Gelpi; Isidre Ferrer; Walter J Schulz-Schaeffer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2016-06-20       Impact factor: 5.590

Review 5.  Etiology and pathogenesis of prion diseases.

Authors:  S J DeArmond; S B Prusiner
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

Review 6.  Inherited prion diseases.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

7.  Polymorphisms of the prion protein gene (PRNP) in a Korean population.

Authors:  Byung-Hoon Jeong; Jae-Hwan Nam; Yun-Jung Lee; Kyung-Hee Lee; Myoung-Kuk Jang; Richard I Carp; Ho-Dong Lee; Young-Ran Ju; Sangmee Ahn Jo; Keun-Yong Park; Yong-Sun Kim
Journal:  J Hum Genet       Date:  2004-05-18       Impact factor: 3.172

Review 8.  A novel mechanism of phenotypic heterogeneity demonstrated by the effect of a polymorphism on a pathogenic mutation in the PRNP (prion protein gene).

Authors:  R B Petersen; L G Goldfarb; M Tabaton; P Brown; L Monari; P Cortelli; P Montagna; L Autilio-Gambetti; D C Gajdusek; E Lugaresi
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

Review 9.  Neurodegeneration in humans caused by prions.

Authors:  S B Prusiner
Journal:  West J Med       Date:  1994-09

10.  PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism.

Authors:  Matthew T Bishop; Catherine Pennington; Craig A Heath; Robert G Will; Richard S G Knight
Journal:  BMC Med Genet       Date:  2009-12-26       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.